Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development
Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin
Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin
View: Text | PDF
Research Article Development Inflammation Pulmonology

Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development

  • Text
  • PDF
Abstract

Fibroblasts in the lung mesenchyme produce growth factors and extracellular matrix components that guide formation of distal airspaces during the saccular stage of lung development. Inflammation in preterm infants disrupts this process, leading to bronchopulmonary dysplasia (BPD). To examine how mesenchymal inflammation contributes to BPD pathogenesis, we developed a transgenic mouse model (IKKβTbx4) in which expression of activated human IκB kinase β (IKKβ), an upstream activator of NF-κB, was induced in Tbx4 lung enhancer–positive mesenchymal cells during the saccular stage of lung development (P0–P5). Saccular-stage IKKβTbx4 mice exhibited a BPD-like phenotype with interstitial thickening and reduced distal airspaces at P5, progressing to emphysematous enlargement of the distal lung at 2 months of age. Mesenchymal NF-κB activity upregulated the chemokines CCL2 and CCL7, recruiting CCR2pos monocyte-derived macrophages to the lung. Recruited macrophages disrupted the elastin scaffold and impaired microvascular organization with reductions in CAP2 endothelial cells and pericytes. Blocking CCR2-dependent monocyte recruitment with a small-molecule CCR2 antagonist rescued the abnormal lung phenotype. These findings identify mesenchyme-macrophage crosstalk as a mechanism by which inflammation disrupts saccular-stage lung development, suggesting a role for this signaling axis in BPD pathogenesis.

Authors

Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin

×

Figure 3

IKKβTbx4 mouse lung fibroblasts produce chemokines that recruit macrophages.

Options: View larger image (or click on image) Download as PowerPoint
IKKβTbx4 mouse lung fibroblasts produce chemokines that recruit macropha...
(A and B) Primary lung fibroblasts were isolated from IKKβTbx4 and littermate control (CTRL) lungs on P2 and were treated with doxycycline (3 μg/mL in media) at passage 4 or 5. Conditioned media was collected after 24 hours. Conditioned media from CTRL and IKKβTbx4 lung fibroblasts was added to the bottom well of a modified Boyden chamber. RAW 264.7 cells (50,000 per insert) were added to the top chamber (A) and migrated macrophages were fixed, stained, imaged, and counted (B). (C) Chemokine protein levels were quantified in fibroblast conditioned media using a 32-cytokine/chemokine multiplex assay and CCL7 ELISA. (D) Doxycycline was added to drinking water of lactating dams from P0 to P5. Lungs from CTRL and IKKβTbx4 mice were harvested on P5. Chemokine protein levels were quantified in lung lysate using a 32-cytokine/chemokine multiplex assay and CCL7 ELISA. Full multiplex and ELISA results are shown in Supplemental Tables 2 and 3. Inflammatory protein concentrations in lung lysate were normalized to total lung protein content. Data are expressed as mean ± SEM. n = 6 Transwells per group and n = 5 fields per Transwell membrane (B); n = 4 biological replicates per group (C); n = 5 mice per group (D); † = analyte measured using ELISA; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by unpaired 2-tailed t test (B–D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts